Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.bms.com
Get the latest updates from Press Release directly as they happen.
Follow now 141 followers
Last updated about 4 years ago
about 4 years ago
Dateline City NEW YORK NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today...
about 4 years ago
Dateline City PRINCETON, N.J. In the QUAZAR® AML-001 study, Onureg significantly improved...
about 4 years ago
Dateline City PRINCETON, N.J. DAYBREAK trial represents longest safety and efficacy analysis...
about 4 years ago
Dateline City PRINCETON, N.J. PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced...
about 4 years ago
Dateline City NEW YORK & MONTREAL Forbius’s Lead TGF-beta Asset, AVID200, is...
about 4 years ago
Dateline City NEW YORK & WALTHAM, Mass. Agreement Includes DF6002, With Potential...
about 4 years ago
Dateline City PRINCETON, N.J. Five–year commitment builds on long-standing investment in health...
about 4 years ago
Dateline City PRINCETON, N.J. Opdivo is the first and only PD-1 inhibitor...
about 4 years ago
Dateline City PRINCETON, N.J. Opdivo is the first and only treatment to...
about 4 years ago
Dateline City PRINCETON, N.J. CheckMate -743 is the first and only Phase...
about 4 years ago
Dateline City NEW YORK Reports Second Quarter Revenues of $10.1 Billion Posts...
about 4 years ago
Dateline City PRINCETON, N.J., and NEW YORK, N.Y. Contacts Bristol-Myers Squibb Media:...